• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

克罗地亚不同人群中爱泼斯坦-巴尔病毒的血清流行病学研究。

Seroepidemiological Study of Epstein-Barr Virus in Different Population Groups in Croatia.

作者信息

Beader Nataša, Kolarić Branko, Slačanac Domagoj, Tabain Irena, Vilibić-Čavlek Tatjana

机构信息

Department of Microbiology, School of Medicine, University of Zagreb, Zagreb, Croatia.

Department of Clinical and Molecular Microbiology, University Hospital Centre Zagreb, Zagreb, Croatia.

出版信息

Isr Med Assoc J. 2018 Feb;20(2):86-90.

PMID:29431301
Abstract

BACKGROUND

The Epstein-Barr virus (EBV) is one of the most common viruses found in humans, causing lifelong infection in up to 95% of the world population.

OBJECTIVES

To analyze the seroprevalence of EBV infection in different population groups in Croatia.

METHODS

During a 2 year period (2015-2016), a total of 2022 consecutive serum samples collected from Croatian residents were tested for the presence of EBV-specific viral capsid antigen (VCA) immunoglobulin M (IgM) and IgG antibodies using an enzyme-linked immunoassay. IgM/IgG-positive samples were further tested for IgG avidity.

RESULTS

The overall prevalence of EBV IgG antibodies was 91.4%. Females had significantly higher IgG seroprevalence than males (93.1% vs. 89.9%, P = 0.008). According to age, IgG seropositivity increased progressively from 59.6% in children age < 9 years to 98.3% in 30-39 year olds, and remained stable thereafter (P < 0.001). The IgG seroprevalence differed significantly among groups: 68.1% in children/adolescents and 95.9% in adults; multiple sclerosis (100%), hemodialysis patients (97.7%), heart transplant recipients (93.8%), hematological malignancies (91.2%), and Crohn's disease (88.5%), P < 0.001. IgM antibodies were detected in 9% of participants. Using IgG avidity, recent primary EBV infection was documented in 83.8% of IgM-positive subjects < 9 years old, 69.2% age 10-19, 33.3% age 20-29, and 3.6-4.2% > 40. All IgM positive participants > 40 years showed high IgG avidity. Logistic regression showed that age is associated with EBV IgG seropositivity.

CONCLUSIONS

EBV is widespread in the Croatian population. Older age appears to be the main risk factor for EBV seropositivity.

摘要

背景

爱泼斯坦-巴尔病毒(EBV)是人类最常见的病毒之一,全球高达95%的人口会受到其终身感染。

目的

分析克罗地亚不同人群中EBV感染的血清流行率。

方法

在2年期间(2015 - 2016年),使用酶联免疫吸附测定法对从克罗地亚居民中连续采集的2022份血清样本进行检测,以确定是否存在EBV特异性病毒衣壳抗原(VCA)免疫球蛋白M(IgM)和IgG抗体。对IgM/IgG阳性样本进一步检测IgG亲和力。

结果

EBV IgG抗体的总体流行率为91.4%。女性的IgG血清流行率显著高于男性(93.1%对89.9%,P = 0.008)。按年龄划分,IgG血清阳性率从9岁以下儿童的59.6%逐渐上升至30 - 39岁人群的98.3%,此后保持稳定(P < 0.001)。IgG血清流行率在不同组间存在显著差异:儿童/青少年为68.1%,成人为95.9%;多发性硬化症患者(100%)、血液透析患者(97.7%)、心脏移植受者(93.8%)、血液系统恶性肿瘤患者(91.2%)和克罗恩病患者(88.5%),P < 0.001。9%的参与者检测到IgM抗体。通过IgG亲和力检测,9岁以下IgM阳性受试者中83.8%、10 - 19岁者中69.2%、20 - 29岁者中33.3%以及40岁以上者中3.6 - 4.2%被记录为近期原发性EBV感染。所有40岁以上的IgM阳性参与者均显示高IgG亲和力。逻辑回归分析表明年龄与EBV IgG血清阳性相关。

结论

EBV在克罗地亚人群中广泛存在。年龄较大似乎是EBV血清阳性的主要危险因素。

相似文献

1
Seroepidemiological Study of Epstein-Barr Virus in Different Population Groups in Croatia.克罗地亚不同人群中爱泼斯坦-巴尔病毒的血清流行病学研究。
Isr Med Assoc J. 2018 Feb;20(2):86-90.
2
Prevalence of primary versus reactivated Epstein-Barr virus infection in patients with VCA IgG-, VCA IgM- and EBNA-1-antibodies and suspected infectious mononucleosis.VCA IgG、VCA IgM和EBNA-1抗体呈阳性且疑似传染性单核细胞增多症患者中原发性与再激活型爱泼斯坦-巴尔病毒感染的患病率
J Clin Virol. 2007 Apr;38(4):292-7. doi: 10.1016/j.jcv.2007.01.006. Epub 2007 Mar 1.
3
Seroepidemiology of cytomegalovirus infections in Croatia.克罗地亚巨细胞病毒感染的血清流行病学
Wien Klin Wochenschr. 2017 Feb;129(3-4):129-135. doi: 10.1007/s00508-016-1069-7. Epub 2016 Sep 6.
4
Evaluation the Architect EBV VCA IgM, VCA IgG, and EBNA-1 IgG chemiluminescent immunoassays to assess EBV serostatus prior transplantation.评估 Architect EBV VCA IgM、VCA IgG 和 EBNA-1 IgG 化学发光免疫分析,以评估移植前的 EBV 血清状态。
J Med Virol. 2017 Nov;89(11):2003-2010. doi: 10.1002/jmv.24889. Epub 2017 Aug 1.
5
Association of clinical and serological parameters of systemic lupus erythematosus patients with Epstein-Barr virus antibody profile.系统性红斑狼疮患者的临床和血清学参数与 Epstein-Barr 病毒抗体谱的关联。
J Med Virol. 2018 Mar;90(3):559-563. doi: 10.1002/jmv.24904. Epub 2017 Nov 29.
6
Measurement of EBV-IgG anti-VCA avidity aids the early and reliable diagnosis of primary EBV infection.EBV-IgG抗VCA亲和力的测定有助于原发性EBV感染的早期可靠诊断。
J Med Virol. 2003 Aug;70(4):617-23. doi: 10.1002/jmv.10439.
7
[Evaluation of immunoblot-based assay for detecting Epstein-Barr virus viral capsid antibodies].基于免疫印迹法检测爱泼斯坦-巴尔病毒衣壳抗体的分析评估
Mikrobiyol Bul. 2010 Apr;44(2):231-6.
8
Investigation of atypical serological profiles for Epstein-Barr virus (EBV).探讨 EBV 不典型血清学特征。
J Virol Methods. 2024 Sep;329:115002. doi: 10.1016/j.jviromet.2024.115002. Epub 2024 Jul 26.
9
[Atypical profile problem in serological diagnosis of EBV].[EB病毒血清学诊断中的非典型谱问题]
Mikrobiyol Bul. 2017 Oct;51(4):378-386. doi: 10.5578/mb.58662.
10
Evaluation of the Architect Epstein-Barr Virus (EBV) viral capsid antigen (VCA) IgG, VCA IgM, and EBV nuclear antigen 1 IgG chemiluminescent immunoassays for detection of EBV antibodies and categorization of EBV infection status using immunofluorescence assays as the reference method.以免疫荧光法为参考方法,评估Architect爱泼斯坦-巴尔病毒(EBV)病毒衣壳抗原(VCA)IgG、VCA IgM和EBV核抗原1 IgG化学发光免疫分析法用于检测EBV抗体及对EBV感染状态进行分类的情况。
Clin Vaccine Immunol. 2014 May;21(5):684-8. doi: 10.1128/CVI.00104-14. Epub 2014 Mar 12.

引用本文的文献

1
Equity in protection: bridging global data gaps for an EBV vaccine-a systematic review and meta-analysis.保护公平性:弥合全球EBV疫苗数据差距——一项系统评价与荟萃分析
BMJ Glob Health. 2025 Aug 14;10(8):e015534. doi: 10.1136/bmjgh-2024-015534.
2
Clinical Features and Laboratory Findings of Hospitalized Children with Infectious Mononucleosis Caused by Epstein-Barr Virus from Croatia.来自克罗地亚的感染性单核细胞增多症住院儿童的临床特征和实验室检查结果,该疾病由爱泼斯坦-巴尔病毒引起
Pathogens. 2025 Apr 10;14(4):374. doi: 10.3390/pathogens14040374.
3
Epstein-Barr Virus Seroprevalence in Thailand: A Temporal and Global Perspective with Health Care and Economic Correlations.
泰国的爱泼斯坦-巴尔病毒血清流行率:从时间和全球视角看与医疗保健及经济的相关性
Am J Trop Med Hyg. 2025 Apr 29;113(1):86-93. doi: 10.4269/ajtmh.24-0857. Print 2025 Jul 2.
4
Epidemiological characteristics of three herpesviruses infections in children in Nanjing, China, from 2018 to 2023.中国南京地区 2018 年至 2023 年三种疱疹病毒感染的流行病学特征。
Front Cell Infect Microbiol. 2024 Oct 3;14:1448533. doi: 10.3389/fcimb.2024.1448533. eCollection 2024.
5
Serum Concentrations of Chemokines CCL20, CXCL8 and CXCL10 in Relapsing-Remitting Multiple Sclerosis and Their Association with Presence of Antibodies against Epstein-Barr Virus.血清趋化因子 CCL20、CXCL8 和 CXCL10 在复发缓解型多发性硬化症中的浓度及其与抗 Epstein-Barr 病毒抗体存在的关系。
Int J Mol Sci. 2024 Jul 24;25(15):8064. doi: 10.3390/ijms25158064.
6
A combined antibody and DNA assay for EBV infection in children.一种用于检测儿童EB病毒感染的联合抗体和DNA检测方法。
Front Pediatr. 2022 Aug 25;10:989193. doi: 10.3389/fped.2022.989193. eCollection 2022.
7
Epstein-Barr Virus (EBV) Genotypes Associated with the Immunopathological Profile of People Living with HIV-1: Immunological Aspects of Primary EBV Infection. Epstein-Barr 病毒(EBV)基因型与 HIV-1 感染者免疫病理特征的关系:原发性 EBV 感染的免疫学方面。
Viruses. 2022 Jan 18;14(2):168. doi: 10.3390/v14020168.
8
Epidemiological risk factors associated with primary infection by Epstein-Barr virus in HIV-1-positive subjects in the Brazilian Amazon region.与巴西亚马逊地区 HIV-1 阳性个体原发性 EBV 感染相关的流行病学风险因素。
Sci Rep. 2021 Sep 16;11(1):18476. doi: 10.1038/s41598-021-97707-4.
9
Cytomegalovirus and Epstein-Barr Infections: Prevalence and Impact on Patients with Hematological Diseases.巨细胞病毒和 Epstein-Barr 病毒感染:血液系统疾病患者的流行情况及其影响。
Biomed Res Int. 2020 Oct 24;2020:1627824. doi: 10.1155/2020/1627824. eCollection 2020.
10
Prevalence and molecular epidemiology of CMV and EBV among nurses working in pediatrics, transplantology, and primary health care.儿科、移植科和初级保健工作的护士中 CMV 和 EBV 的流行情况及分子流行病学研究。
J Occup Health. 2020 Jan;62(1):e12112. doi: 10.1002/1348-9585.12112.